The importance of heart rate variability in predicting cardiac autonomic dysfunction in patients with amyotrophic lateral sclerosis

dc.authorid0000-0001-9211-6534
dc.authorid0000-0002-8427-4097
dc.authorid0000-0003-4922-6556
dc.authorid0000-0001-8594-7540
dc.contributor.authorİşcan, Dilek
dc.contributor.authorKaraaslan, Muhammet Buğra
dc.contributor.authorDeveci, Onur Sinan
dc.contributor.authorAkıllı Eker, Rabia
dc.contributor.authorKoç, Filiz
dc.date.accessioned2025-10-13T06:12:47Z
dc.date.available2025-10-13T06:12:47Z
dc.date.issued2021
dc.departmentTıp Fakültesi
dc.description.abstractAim: Amyotrophic lateral sclerosis (ALS) is a progressive disease characterized by degeneration in the upper and lower motor neurons of the corticospinal tract, brain stem, and spinal cord. Recent studies have revealed that the disease does not present solely with motor neuron involvement. Accordingly, the aim of this study is to investigate the presence of cardiac autonomic impairment in patients diagnosed with ALS. Material and Method: A total of 61 patients, who were diagnosed with ALS according to the Revised El Escorial Criteria (R-EEC), were included in this prospective study, in addition to the 29 healthy individuals, who were included in the study as controls. In order to assess the cardiac autonomic involvement, the presence of orthostatic hypotension was investigated, and transthoracic echocardiography and 24-hour electrocardiogram (ECG) using a Holter monitor were performed. Results: Orthostatic hypotension was detected in 14 (22.2%) patients. Holter electrocardiogram results of the patient group revealed statistically significantly lower heart rate variability (HRV) indicators in the time domain (SDNN, SDANN, SDNN index, rMSSD, and pNN50) and in the frequency domain (high frequency [HF], low frequency [LF], and very low frequency [VLF]) than those of the control group (P <.05). Conclusion: Contrary to the popular opinion, cardiac autonomic dysfunction in patients with ALS can occur at any stage of the disease. Therefore, it is recommended that the patients are evaluated via periodic examinations during the follow-up period for cardiac autonomic involvement.
dc.identifier.doi10.1111/ijcp.14536
dc.identifier.issn13685031
dc.identifier.issue10
dc.identifier.pmid34132003
dc.identifier.scopus2-s2.0-85108970449
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1111/ijcp.14536
dc.identifier.urihttps://hdl.handle.net/20.500.12451/14701
dc.identifier.volume75
dc.indekslendigikaynakPubMed
dc.indekslendigikaynakScopus
dc.institutionauthorİşcan, Dilek
dc.institutionauthorid0000-0002-0773-7780
dc.language.isoen
dc.publisherJohn Wiley and Sons Inc
dc.relation.ispartofInternational Journal of Clinical Practice
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAmyotrophic Lateral Sclerosis
dc.subjectAutonomic Nervous System
dc.subjectHeart
dc.subjectHeart Rate
dc.subjectHumans
dc.subjectProspective Studies
dc.titleThe importance of heart rate variability in predicting cardiac autonomic dysfunction in patients with amyotrophic lateral sclerosis
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
iscan-dilek-2021.pdf
Boyut:
636.98 KB
Biçim:
Adobe Portable Document Format
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: